{
    "stakeholders": [
      {
        "group": "MetroCare Executive Leadership",
        "primary_concerns": [
          "Financial viability of the AI system",
          "Return on investment",
          "Strategic alignment",
          "Liability and compliance"
        ],
        "impact_level": "High",
        "representation_status": "Fully Represented"
      },
      {
        "group": "Physicians and Clinical Staff",
        "primary_concerns": [
          "Accuracy of AI diagnoses",
          "Impact on clinical workflows",
          "Job security or role change",
          "Training and adaptation costs"
        ],
        "impact_level": "High",
        "representation_status": "Fully Represented"
      },
      {
        "group": "Patients (Urban & Rural)",
        "primary_concerns": [
          "Privacy and confidentiality of data",
          "Equitable quality of care",
          "Bias in AI model performance",
          "Autonomy and informed consent"
        ],
        "impact_level": "High",
        "representation_status": "Partially Represented"
      },
      {
        "group": "Rural Community Advocates",
        "primary_concerns": [
          "Inclusivity of AI data sets",
          "Access to advanced diagnostic tools",
          "Potential algorithmic bias",
          "Healthcare disparity reduction"
        ],
        "impact_level": "High",
        "representation_status": "Partially Represented"
      },
      {
        "group": "Data Privacy Advocates",
        "primary_concerns": [
          "Data protection regulations",
          "Risk of unauthorized access or breaches",
          "Ethical handling of patient information",
          "Vendor compliance with privacy standards"
        ],
        "impact_level": "Medium",
        "representation_status": "Uncertain"
      },
      {
        "group": "Government and Regulatory Bodies",
        "primary_concerns": [
          "Regulatory compliance",
          "Public trust in AI healthcare",
          "Patient safety standards",
          "Oversight of data sharing"
        ],
        "impact_level": "Medium",
        "representation_status": "Fully Represented"
      },
      {
        "group": "Health Insurers and Payers",
        "primary_concerns": [
          "Cost impact and reimbursement models",
          "Accuracy of AI-driven diagnoses for claims",
          "Potential shift in risk profiles",
          "Data usage in underwriting"
        ],
        "impact_level": "Medium",
        "representation_status": "Fully Represented"
      },
      {
        "group": "AI Vendor",
        "primary_concerns": [
          "Continuous data collection for model updates",
          "Profitability and contractual terms",
          "Access to diverse patient data",
          "Maintaining product reputation"
        ],
        "impact_level": "High",
        "representation_status": "Fully Represented"
      },
      {
        "group": "IT Department",
        "primary_concerns": [
          "Technical infrastructure readiness",
          "Integration with existing systems",
          "Cybersecurity implications",
          "Scalability and maintenance"
        ],
        "impact_level": "Medium",
        "representation_status": "Partially Represented"
      }
    ],
    "stakeholder_relationships": [
      {
        "group1": "MetroCare Executive Leadership",
        "group2": "Physicians and Clinical Staff",
        "relationship_type": "Collaborative governance",
        "potential_conflicts": [
          "Budget allocation for training",
          "Workflow redesign disagreements"
        ]
      },
      {
        "group1": "MetroCare Executive Leadership",
        "group2": "AI Vendor",
        "relationship_type": "Contractual partnership",
        "potential_conflicts": [
          "Long-term cost commitments",
          "Ownership of patient data"
        ]
      },
      {
        "group1": "Patients (Urban & Rural)",
        "group2": "Data Privacy Advocates",
        "relationship_type": "Shared interest in privacy",
        "potential_conflicts": [
          "Balancing personalization vs. privacy",
          "Consent management complexities"
        ]
      },
      {
        "group1": "Rural Community Advocates",
        "group2": "AI Vendor",
        "relationship_type": "Stakeholder representation",
        "potential_conflicts": [
          "Insufficient rural data representation",
          "Risk of biased model outcomes"
        ]
      },
      {
        "group1": "Government and Regulatory Bodies",
        "group2": "MetroCare Executive Leadership",
        "relationship_type": "Regulatory oversight",
        "potential_conflicts": [
          "Compliance burden vs. innovation",
          "Data-sharing policies"
        ]
      },
      {
        "group1": "Health Insurers and Payers",
        "group2": "MetroCare Executive Leadership",
        "relationship_type": "Negotiation and funding",
        "potential_conflicts": [
          "Coverage of AI-driven diagnostics",
          "Risk-sharing models"
        ]
      },
      {
        "group1": "IT Department",
        "group2": "Physicians and Clinical Staff",
        "relationship_type": "Technical support and training",
        "potential_conflicts": [
          "Resource constraints",
          "System downtime or delays"
        ]
      },
      {
        "group1": "AI Vendor",
        "group2": "Data Privacy Advocates",
        "relationship_type": "Compliance and risk mitigation",
        "potential_conflicts": [
          "Use of sensitive patient information",
          "Transparency in AI model updates"
        ]
      }
    ]
  }